Novel urine-based DNA methylation biomarkers for urothelial bladder carcinoma detection in patients with hematuria

References

• Saginala K, Barsouk A, Aluru JS, et al. Epidemiology of bladder cancer. Med Sci. 2020;8(1):15.
   Google Scholar
• Waisbrod S, Natsos A, Wettstein MS, et al. Assessment of diagnostic yield of cystoscopy and computed tomographic urography for urinary tract cancers in patients evaluated for microhematuria: a systematic review and meta-analysis. JAMA Netw Open. 2021;4(5):e218409. DOI:10.1001/jamanetworkopen.2021.8409
   PubMed Web of Science ®Google Scholar
• Ghandour R, Freifeld Y, Singla N, et al. Evaluation of hematuria in a large public health care system. Bladder Cancer. 2019;5(2):119–129.
   PubMed Web of Science ®Google Scholar
• Matulewicz RS, Rademaker A, Meeks JJ. A simplified nomogram to assess risk of bladder cancer in patients with a new diagnosis of microscopic hematuria. Urol Oncol. 2020;38(4):240–246.
   PubMed Web of Science ®Google Scholar
• Wallis CJD, Sayyid RK, Manyevitch R, et al. Diagnostic utility of axial imaging in the evaluation of hematuria: a systematic review and critical appraisal of the literature. Can Urol Assoc J. 2020;15(2):48–55. DOI:10.5489/cuaj.6522
   Web of Science ®Google Scholar
• Svatek RS, Hollenbeck BK, Holmäng S, et al. The economics of bladder cancer: costs and considerations of caring for this disease. Eur Urol. 2014;66(2):253–262. DOI:10.1016/j.eururo.2014.01.006
   PubMed Web of Science ®Google Scholar
• Maas M, Bedke J, Stenzl A, et al. Can urinary biomarkers replace cystoscopy? World J Urol. 2019;37(9):1741–1749.
   PubMed Web of Science ®Google Scholar
• Elsawy AA, Awadalla A, Maher S, et al. Diagnostic Performance of Novel Urine-Based mRNA Tests (Xpert and Urinary Metabolomics Markers Assay) for Bladder Cancer Detection in Patients with Hematuria. Bladder Cancer. 2020;6(3):319–28.
   Web of Science ®Google Scholar
• Bosschieter J, Lutz C, Segerink LI, et al. The diagnostic accuracy of methylation markers in urine for the detection of bladder cancer: a systematic review. Epigenomics. 2018;10(5):673–687. DOI:10.2217/epi-2017-0156
   PubMed Web of Science ®Google Scholar
• Hentschel AE, van der Toom EE, Vis AN, et al. A systematic review on mutation markers for bladder cancer diagnosis in urine. BJU Int. 2021;127(1):12–27. DOI:10.1111/bju.15137
   PubMed Web of Science ®Google Scholar
• Chen H, Yu Y, Rong S, et al. Evaluation of diagnostic accuracy of DNA methylation biomarkers for bladder cancer: a systematic review and meta-analysis. Biomarkers. 2014;19(3):189–197.
   PubMed Web of Science ®Google Scholar
• Barkan GA, Wojcik EM, Nayar R, et al. The Paris system for reporting urinary cytology: the quest to develop a standardized terminology. Acta Cytol. 2016;60(3):185–197. DOI:10.1159/000446270
   PubMed Web of Science ®Google Scholar
• Bolenz C, Schröppel B, Eisenhardt A, et al. The investigation of hematuria. Dtsch Arztebl Int. 2018;115(48):801–807.
   PubMed Web of Science ®Google Scholar
• Assmus MA, McLarty R, Senthilselvan A, et al. Direct to cystoscopy: a prospective quality assessment of patient preferences. Can Urol Assoc J. 2020;14(4):118–121.
   PubMed Web of Science ®Google Scholar
• Blackwell RH, Kirshenbaum EJ, Zapf MAC, et al. Incidence of adverse contrast reaction following nonintravenous urinary tract imaging. Eur Urol Focus. 2017;3(1):89–93. DOI:10.1016/j.euf.2016.01.009
   PubMedGoogle Scholar
• Lee HH, Kim SH. Review of non-invasive urinary biomarkers in bladder cancer. Transl Cancer Res. 2020;9(10):6554–6564.
   PubMed Web of Science ®Google Scholar
• Elsawy AA, Harraz AM, Ghobrial FK, et al. Diagnostic performance and predictive capacity of early urine cytology after transurethral resection of nonmuscle invasive bladder cancer: a prospective study. Urol Oncol. 2020;38(12):9.
   Web of Science ®Google Scholar
• Ralla B, Stephan C, Meller S, et al. Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies. Crit Rev Clin Lab Sci. 2014;51(4):200–231.
   PubMed Web of Science ®Google Scholar
• Hentschel AE, Beijert IJ, Bosschieter J, et al. Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation. Clin Epigenetics. 2022;14(1):022–01240. DOI:10.1186/s13148-022-01240-8
   PubMed Web of Science ®Google Scholar
• Dahmcke CM, Steven KE, Larsen LK, et al. A prospective blinded evaluation of urine-DNA testing for detection of urothelial bladder carcinoma in patients with gross hematuria. Eur Urol. 2016;70(6):916–919. DOI:10.1016/j.eururo.2016.06.035
   PubMed Web of Science ®Google Scholar
• Serizawa RR, Ralfkiaer U, Steven K, et al. Integrated genetic and epigenetic analysis of bladder cancer reveals an additive diagnostic value of FGFR3 mutations and hypermethylation events. Int J Cancer. 2011;129(1):78–87. DOI:10.1002/ijc.25651
   PubMed Web of Science ®Google Scholar
• van Kessel KE, Beukers W, Lurkin I, et al. Validation of a DNA methylation-mutation urine assay to select patients with hematuria for cystoscopy. J Urol. 2017;197(3 Part 1):590–595. DOI:10.1016/j.juro.2016.09.118
   PubMed Web of Science ®Google Scholar
• Chan MW, Chan LW, Tang NL, et al. Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients. Clin Cancer Res. 2002;8(2):464–470.
   PubMed Web of Science ®Google Scholar
• Yates DR, Rehman I, Meuth M, et al. Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls. Oncogene. 2006;25(13):1984–1988.
   PubMed Web of Science ®Google Scholar
• Lin HH, Ke HL, Huang SP, et al. Increase sensitivity in detecting superficial, low grade bladder cancer by combination analysis of hypermethylation of E-cadherin, p16, p14, RASSF1A genes in urine. Urol Oncol. 2010;28(6):597–602.
   PubMed Web of Science ®Google Scholar
• Knowles MA, Hurst CD. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat Rev Cancer. 2015;15(1):25–41.
   PubMed Web of Science ®Google Scholar
• Audenet F, Attalla K, Sfakianos JP. The evolution of bladder cancer genomics: what have we learned and how can we use it? Urol Oncol. 2018;36(7):313–320.
   PubMed Web of Science ®Google Scholar
• Zhang S, Zhang J, Zhang Q, et al. Identification of prognostic biomarkers for bladder cancer based on DNA methylation profile. Front Cell Dev Biol. 2022;9(817086). DOI:10.3389/fcell.2021.817086
   Google Scholar